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OBJECTIVES: The ATHENA trial demonstrated that in patients with atrial ﬁbrilla-
tion (AF) and/or atrial ﬂutter (AFL), dronedarone decreased the risk of CV hospitaliza-
tions or death from any cause by 24% (P  0.001). In this retrospective cohort study, 
we evaluated hospitalizations/mortality in three subgroups of real world US insured 
AF/AFL patients without heart failure (HF): 1) patients aged q65 years (with or 
without CV risk factors); 2) ATHENA-like patients (q70 years and q1 CV risk factor); 
and 3) ATHENA-like patients q75 years. METHODS: Data for patients with evidence 
of non-transient AF and/or AFL in 2005 were drawn from the US MarketScan® data-
bases from Thomson Reuters. Patients also had to have q12 months’ continuous 
enrollment pre- and post-AF/AFL index diagnosis (except for inpatient death). 
RESULTS: In the AF/AFL q65 years, ATHENA q70 years, and ATHENA q75 years 
groups, 55,774 (52.2% men), 32,262 (46.2% men) and 24,587 (43.6% men) patients, 
respectively, were identiﬁed. Mean follow up was 24 months in all 3 groups. Across 
the 3 groups, more than half of patients had q1 hospital admission (51.9%, 52.7%, 
and 54.5%, respectively) and almost 30% a hospitalization with a primary CV diag-
nosis (27.2%, 28.2%, and 28.7%, respectively). Inpatient deaths were reported in 
1592 (2.9%) AF/AFL q65 years, 919 (2.8%) ATHENA q70 years, and 798 (3.2%) 
ATHENA q75 years patients. Deaths during hospitalizations for CV causes were 
reported in 516 (0.9%), 327 (1.0%), and 273 (1.1%) patients, respectively. CON-
CLUSIONS: There was a similar rate of hospitalization and mortality between the 
two ATHENA-like groups and the AF/AFL q65 year group. The three patient groups 
studied were frequently hospitalized for all causes and CV events. Dronedarone may 
therefore be of beneﬁt to a large number of ATHENA-like AF/AFL patients in a 
real-world setting. Further studies should evaluate dronedarone in a broader range of 
AF/AFL patients aged q65 years.
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OBJECTIVES: Mediterranean populations are traditionally considered to be associ-
ated with lower incidence of cardiovascular events (CVE). However, this lower inci-
dence could not be homogeneous throughout different patient strata. The hypertensive 
ASCOT-type proﬁle could have a different CV risk than other hypertensive subjects 
without that proﬁle event in Mediterranean settings. The goal of this retrospective 
study was to compare the incidence of CVE and all-causes mortality in hypertensive 
patients with ASCOT-type proﬁle with that of the rest hypertensive subjects. 
METHODS: A retrospective analysis was carried out in BSA claim database. Hyper-
tensive patients without known cardiovascular disease on antihypertensive therapy 
included in the database during year 2006 were followed for two consecutive years 
to ascertain incidence of all-causes mortality and/or any CVE included peripheral 
artery disease. CVE included any of the following: coronary hearth disease, acute 
myocardial infarction (AMI), angina, stroke, transient ischemic attack (TIA), periph-
eral artery disease, any CVE. Blood biochemistry parameters were also recorded. 
Patients with ASCOT-BPLA and ASCOT-LLA type proﬁles were identiﬁed and com-
pared with non-ASCOD-type proﬁle hypertensive subjects. Incidences of event, rela-
tive risk and rate of events were assessed. A Cox-proportional regression model was 
ﬁtted to ascertain crude hazard ratios. RESULTS: A total of 11,104 were included in 
the analysis; 68.0 o 11.4 years, 41.6% males. More than 73% of subjects fulﬁlled 
criteria for ASCOT-type proﬁle. All-causes mortality were higher but not statistically 
signiﬁcant in ASCOT-BPLA and LLA compared with non-ASCOT-type; HR (95% 
CI)  1.3 (0.8–1.9) and 1.6 (0.9–2.8), respectively. However, any-coronary event rates 
were signiﬁcantly higher in ASCOT-type; 3.1 (2.2–4.4, p  0.001) and 2.1 (1.3–3.4, 
p  0.05), and also cerebrovascular disease; 1.6 (1.2–2.2, p  0.05) and 1.5 (1.0–2.3, 
p  0.05), respectively. CONCLUSIONS: Hypertensive patients on treatment with 
ASCOT-type proﬁle are more likely to have any coronary or cerebrovascular events 
than those hypertensive patients without ASCOT proﬁle in a Mediterranean setting 
in Spain.
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OBJECTIVES: The aim of our study was to observe whether a seasonal change or 
weekly variation can be shown in the incidence of an acute myocardial infarction 
(AMI) and a cerebral infarction between 2005 and 2007 in Hungary. METHODS: 
We have analyzed myocardial (N  44.105) and cerebral infarction (N  151.678) 
patients attended in clinics and hospitals in Hungary during the three years examined. 
Data were collected from the database of the National Social Security Fund (OEP) 
based on the International Classiﬁcation of Diseases. RESULTS: Based on our results, 
a weekly and a seasonal variation can be seen in the onset of a myocardial and cerebral 
infarction. With regard to seasonal variation, there was a signiﬁcant difference 
between the number of events for each season (AMI: khi2  78,923, p  0.001 Cerebral 
inf.: khi2  11,1397, p  0.05), and the peek period of myocardial and cerebral infarc-
tion was found during the months of spring, the lowest number of events was during 
the summer. In case of sexes, we found difference only in the seasonal variation in 
case of the number of AMI and cerebral infarction events AMI: khi2  8,671, p  
0.05; Cerebral inf.: khi2  29,277, p  0.001). The weekly peek period of infarction 
and cerebral circulatory disturbance was found on the ﬁrst day of the week, on 
Monday, with a gradually decreasing tendency towards the end of the week. CON-
CLUSIONS: The decrease of the number of events is higher from Friday to Sunday. 
In summary, the results of our study show that the incidence of an acute myocardial 
and a cerebral infarction show characteristic variation with regard to seasons and the 
days of the week.
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OBJECTIVES: In 2008 the European Society of Cardiology (ESC) published guidelines   
on the use of Implantable cardiac devices (ICDs) and cardiac resynchronization       
therapies (CRTs) for primary and secondary prevention of heart failure and sudden 
cardiac arrest. An understanding of the number of persons in Western Europe that 
would be eligible for these therapies under the new guidelines is currently lacking. The 
objective of this study was to estimate the prevalence of eligible persons for ICD and 
CRT in Western Europe according to the ESC guidelines. METHODS: A comprehensive 
systematic review of the literature was undertaken to identify relevant prevalence data. 
Medline, Embase, PubMed, CRD York and The Cochrane Library databases were 
searched from 1990 to August 2008. Grey literature sources were also searched. 
Population-based epidemiological studies that included prevalence or incidence 
estimates of persons eligible for implantation of CRT or ICD devices according to the 
current 2008 ESC guidelines were included. Two reviewers independently extracted 
data from the included studies using a standard template. RESULTS: A total of 1583 
unique articles were retrieved. No one study reported data that met the full eligibility 
criteria for ICDs or CRTs as outlined by the ESC guidelines. Fifteen studies met partial 
criteria and were included for review. General population prevalence estimates of 
persons with individual risk factors such as; LVEF a  35%, NYHA class II, III or IV, 
QRS prolongation (QRS q 120ms), 40 days post MI and survivors of ventricular 
ﬁbrillation were retrieved from the literature. Preliminary modelling of this data 
identiﬁed signiﬁcant gaps in the published estimates. CONCLUSIONS: A 
comprehensive systematic review of the literature has highlighted the lack of general 
population estimates for persons eligible for ICDs or CRTs according to the most 
recent guidelines. Further modelling of this data in combination with estimates from 
primary data sources is warranted.
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OBJECTIVES: Different meteorological factors can play a role in the occurrence of 
cardiovascular diseases. Whether certain meteorological and astronomical factors, and 
the periodical change inﬂuence the bleeding quantity after heart operation. METHODS: 
Retrospective analysis was made on the University of Pécs Cardiotherapy Clinic 
among patients went through heart operation (n  611) between 2007.01.01 and 
2007.12.31. in Hungary. Statistical tests: khí2 test, variance analysis (ANOVA), 
Pearson-Spearman correlation coefﬁcient examination was made. Data processing was 
done with SPSS 15.0 and MS Excel programs. RESULTS: No connection was found 
between the examined meteorological factors and the quantity of total bleeding but 
on the other hand we found connection between the energy of the solar ﬂares and the 
daily average bleeding (p  0.025). Signiﬁcant values were found between the periodi-
cal change and total bleeding (p  0.03). CONCLUSIONS: Postoperative bleeding is 
inﬂuenced by many factors: antecedents of patients, atmosphere and cosmic factors, 
perioperative medication, operative data, surgical technique. The examined factors do 
not affect the bleeding quantity, on the other hand certain astronomical factors do. 
The energy of the solar ﬂare showed a negative correlation with bleeding. The periodi-
cal change inﬂuences postoperative bleeding among patients with open heart 
operation.
